Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab ...
Sep 10, 2021
0
20